Kurth, Jens

Assessing the Safety of Stem Cell Therapeutics

Goldring, C. E. P., Duffy, P. A., Benvenisty, N., Andrews, P. W., Ben-David, U., Eakins, R., French, N., Hanley, N. A., Kelly, L., Kitteringham, N. R., et al. (2011) · Cell Stem Cell

Biomedical Ethics and RegulationPluripotent Stem Cells Research

Cited by 245

Siponimod ameliorates metabolic oligodendrocyte injury via the sphingosine-1 phosphate receptor 5

Behrangi, N., Heinig, L., Frintrop, L., Santrau, E., Kurth, J., Krause, B., Atanasova, D., Clarner, T., Fragoulis, A., Joksch, M., et al. (2022) · Proceedings of the National Academy of Sciences

Multiple Sclerosis Research StudiesSphingolipid Metabolism and Signaling

Cited by 27

Tumor dosimetry of [177Lu]Lu-PSMA-617 for the treatment of metastatic castration-resistant prostate cancer: Results from the VISION trial sub-study.

Krause, B. J., Chi, K. N., Sartor, A. O., Fizazi, K., Morris, M. J., De Bono, J. S., Tagawa, S. T., Herrmann, K., Kurth, J., Eiber, M., et al. (2023) · Journal of Clinical Oncology

Radiopharmaceutical Chemistry and ApplicationsMedical Imaging Techniques and Applications

Cited by 11